Colorado BioScience Association

What does world-class intellectual property strategy look like in today's life sciences industry?

Join Colorado BioScience Association and Wilson Sonsini Goodrich & Rosati for an exclusive Thought Leadership Series event, featuring the executives and innovators responsible for protecting and maximizing the value of breakthrough technologies at some of the most influential companies in biotech, genomics, diagnostics, and precision medicine.

Our distinguished panel includes the following intellectual property leaders:

- B.C. Moore, Director, Global Intellectual Property, Illumina

- Rachel Herder, SVP, Legal & Alliance Management (Head of IP), Mammoth Biosciences

- Paul Wickman, SVP, Intellectual Property, Ultragenyx

- Ben Carver, General Counsel, Ambrosia Biosciences Inc.

- Sara P., Partner, Wilson Sonsini

- Bill Barrett, Founder & CEO, TechNomos AI; former Wilson Sonsini partner and former senior IP executive at Illumina and GRAIL

Collectively, these experts have led IP strategy for CRISPR technologies, next-generation sequencing platforms, precision diagnostics, rare disease therapeutics, venture-backed startups, public companies, major acquisitions, licensing transactions, and patent portfolios worth billions of dollars in enterprise value.

If you're a biotech founder, executive, investor, scientist, attorney, or innovation leader, this is a conversation you won't want to miss.

Register Today: https://cobioscience.my.site.com/s/event-details?event=a2HVu00000lTPeI

Senator Michael Bennet met with leaders of Foresight Diagnostics (a Natera company) and Colorado BioScience Association Vice President and Counsel for Policy + Advocacy Amy Berenbaum Goodman, JD, MBE in Boulder last week.

The conversations covered Foresight's leadership in diagnostics and the importance of legislation at the federal and state level to expand reimbursement and insurance coverage for next-generation diagnostics.

CBSA thanks the Foresight Diagnostics and Natera teams for the tour and insightful conversations.

Read more about Foresight's growth in Colorado in our BioScience Colorado Magazine: https://cobioscience.com/flipbooks/11/flipbook/?page=28